Viking Therapeutics: Peers

The FY2025 (Dec) proxy of Viking Therapeutics names 18 peer companies for pay. Among Viking Therapeutics and these peers, CEO pay was the highest of 8 and total shareholder return was the highest of 8.

1st highest of 8in Viking Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$10.4M$21.3M

1st highest of 8in Viking Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

$108$625

Pay peer group, FY2025 (Dec) proxy

Madrigal Pharmaceuticals
United Therapeutics
BridgeBio Pharma
Revolution Medicines
Protagonist Therapeutics
Cytokinetics
Krystal Biotech
Akero Therapeutics, Inc.Not disclosedNot disclosed
Amicus Therapeutics, Inc.Not disclosedNot disclosed
Arrowhead Pharmaceuticals, Inc.Not disclosedNot disclosed
Avidity Biosciences, Inc.Not disclosedNot disclosed
Crinetics Pharmaceuticals, Inc.Not disclosedNot disclosed
Dyne Therapeutics, Inc.Not disclosedNot disclosed
Intra-Cellular Therapies, Inc.Not disclosedNot disclosed
Rhythm PharmaceuticalsNot disclosedNot disclosed
SpringWorks Therapeutics, Inc.Not disclosedNot disclosed
Summit TherapeuticsNot disclosedNot disclosed
VaxcyteNot disclosedNot disclosed
18 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.